Clinical Relevance: The goal of this study is to examine how successful faculty who have obtained OREF grants have been in securing NIH funding later in their careers. Although subsequent accrual of NIH funding is not the only goal of OREF funding, it can be used as an important benchmark to assess the development of orthopaedic clinicianscientists.
The Orthopaedic Research and Education Foundation (OREF) is the preeminent nongovernmental organization funding research across orthopaedic subspecialties in the United States. Since its inception in 1955, the OREF has awarded more than $143 million for 4,700 research and education initiatives 1 . One of the stated goals of the OREF is to promote career development for faculty in orthopaedic surgery who plan to make basic science research, clinical research, or epidemiological research a component of their careers. These grants were intended to assist junior faculty in establishing their research platforms, potentially laying the foundation to secure larger grants from other funding sources, such as the National Institutes of Health (NIH).
In light of the recent trend toward cutbacks for research support, the ability of faculty to secure extramural funding has become increasingly challenging [2] [3] [4] . The pursuit of progressively scarce research support compounds the challenges of an academic practice, particularly for junior faculty for whom the accrual of seed money to help to perform pilot studies and to establish research platforms is crucial. The OREF serves an important function in targeting and funding those researchers most likely to be successful in the future. Yet no study to date, to our knowledge, has evaluated the success of the OREF grant programs at enabling accrual of subsequent extramural funding or variables that may improve the rate of that success.
The purpose of this study was twofold: first, to determine the conversion rate of OREF grantees in subsequently garnering federal NIH support, and second, to identify potential attributes of OREF awardees that are associated with a higher likelihood of future NIH funding.
Materials and Methods

Rate of Conversion of OREF Award into Future NIH Funding Success
Data regarding all OREF grant awards from 1994 to 2014, including principal investigator, institution, project title, grant type, year awarded, and amount awarded, were generously provided by the OREF upon request from the authors. Grants afforded to part-time faculty, volunteer faculty, or residents were excluded in an effort to assess the translation of faculty-level grants in securing future federal funding. Five OREF grant categories were therefore included in our analysis: the Career Development Grant ($134,000 to $225,000), the Zimmer Orthopaedic Career Development Grant ($50,000), the Career Development Grant in Total Joint and Trauma Surgery ($50,000), the Young Investigator Grant ($50,000), and the New Investigator Grant ($50,000). This resulted in the inclusion of 128 total faculty-level OREF grant awards to 123 different individuals. The Career Development Grant was compared with the other 4 grants in a separate analysis given differences in the size and scope of the grants, with 3 years and $134,000 to $225,000 for the Career Development Grant compared with 1 year and $50,000 each for the other 4 grants.
The NIH RePORTER web site, which contains NIH grant information from 1992 to the present, was utilized to query all OREF awardees for NIH funding and type of NIH grant 5 . Only faculty who were principal investigators on an NIH grant were considered NIH award winners. Given the aim of the study to determine OREF grant translation into subsequent federal funding, of the 123 individuals who received grants, 2 faculty were excluded because they received NIH funding prior to receiving an OREF grant award, leaving 121 grants recipients for 126 grants.
OREF Awardee Variables Associated with Future NIH Funding Success
OREF grants were categorized in this study as basic science, clinical, or epidemiological in focus 6 , with basic science studies further subcategorized into those involving cell biology compared with biomechanical studies. All OREF awardees were searched using the American Academy of Orthopaedic Surgeons (AAOS) web site to determine their practice setting and subspecialty. Individual department web sites of recipients were queried for further practice details. Awardees were stratified into the 
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following 9 commonly accepted orthopaedic subspecialties: sports, arthroplasty, oncology, pediatrics, trauma, hand, foot and ankle, shoulder and elbow, and spine. The subspecialty assigned to the awardees was taken on the basis of their primary subspecialty designation on their department web site. The Scopus database was then queried for all included subjects to determine publication experience and scholarly impact, as measured by the h-index 7 . An individual's h-index is defined as the number of an investigator's publications (h) that have been cited at least h times 8 . The h-index as a measure of scholarly productivity and potential has been validated in several subspecialties within academic medicine, including neurosurgery, dermatology, and orthopaedic surgery [9] [10] [11] [12] [13] [14] [15] . An awardee's h-index in the year in which he or she won the OREF award was recorded using the h-index graph in the Scopus database, which displays an individual's h-index over time. Each awardee's h-index was also recorded at the time of data collection, in September 2016, and was considered as the current h-index score. Publication experience was defined as the number of years from an individual's first publication to the year of his or her OREF award.
Statistical analysis was performed using the Mann-Whitney U test for continuous data and the Pearson chi-square test for categorical data. A p value of <0.05 was considered significant. Odds ratios (ORs) were calculated using 2-by-2 frequency tables in Excel 2010 (Microsoft).
Results
On the basis of our methodology, of the 121 individual OREF grant recipients since 1994, all 121 recipients were full-time Doctor of Medicine (MD) faculty serving in an academic orthopaedic surgery department. Of these 121 recipients, 27 faculty-level OREF awardees (22%) later received 31 NIH funding grants ( Fig. 1-A) . Of the 27 NIH awardees, 8 (30%) had an MD and a Doctor of Philosophy (PhD). Of the remaining 94 OREF awardees who did not receive NIH finding, 7 (7%) had an MD and PhD. Thus, 53% (8 of 15) of the MD plus PhDs subsequently received NIH funding, and 18% (19 of 106) of the MDs subsequently received NIH funding. Five investigators received 2 different OREF awards. All 5 received a non-Career Development Grant followed by a Career Development Grant for cell biology basic science work. Two (40%) of these 5 awardees received a subsequent NIH award.
When stratified by award type, 19 (46%) of the 41 awardees for the 3-year Career Development Grant later received NIH funding ( Fig. 1-B) , compared with 10 (12%) of the 85 awardees for the other 1-year awards ( Fig. 1-C) Table I) . When stratified by the type of NIH award won, 24 grants (77%) were R grants, 2 grants (7%) were K grants, 2 grants (7%) were P grants, and 3 grants (10%) were I grants (Table II) .
Awards by Study Type
Of the 126 total OREF grants, 73 were categorized as basic science projects, 45 were categorized as clinical projects, and 8 were categorized as epidemiological projects. Of the basic science projects, 58 were categorized as cell biology and 15 were categorized as biomechanical. Of the 29 OREF grant recipients who later received NIH funding, 24 (83%) received OREF funding for a basic science project and 5 (17%) received OREF funding for a non-basic-science project (Fig. 2) . Faculty members with a basic science project were more than 4 times as likely to receive NIH funding than faculty with a non-basicscience project (OR, 4.70 [95% CI, 1.66 to 13 .33]; p = 0.0036). There were no differences in study type when comparing Career Development Grant awardees with non-Career Development Grant awardees.
Awards by Subspecialty
The proportion of OREF awardees receiving NIH funding was stratified by orthopaedic subspecialty: sports (5 of 17), 
Figs. 2-A, 2-B, and 2-C OREF grants by project study type and the relationship to NIH funding. OREF grants are categorized into 1 of 4 study types: basic science with an emphasis on cell biology, basic science with a biomechanical emphasis, clinical, or epidemiological. showing grants receiving NIH funding compared with those not receiving NIH funding by study type. 16, 2017 arthroplasty (5 of 25), oncology (4 of 17), pediatrics (5 of 10), trauma (2 of 17), hand (2 of 8), foot and ankle (2 of 6), shoulder and elbow (2 of 7), and spine (0 of 14) (Fig. 3) .
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Publication Experience and Scholarly Impact of Awardees
Compared with OREF awardees who did not receive NIH funding, OREF awardees who received NIH funding had a significantly higher h-index both at the time of their OREF award, at 14.97 for OREF awardees receiving NIH funding compared with 9.31 for awardees who did not receive NIH funding (p = 0.003), and currently, at 24.48 for OREF awardees receiving NIH funding compared with 16.70 for awardees who did not receive NIH funding (p = 0.002). When comparing faculty receiving NIH funding by grant type, Career Development Grant winners had a significantly higher h-index than non-Career Development Grant winners both at the time of their OREF award, at 17.0 compared with 11.1 (p = 0.03) and currently, at 26.25 compared with 14.50 (p < 0.001). In addition, the mean time from first publication to the OREF grant was significantly longer (p = 0.0006) for those awardees who received NIH funding (12.16 years) than those who did not receive NIH funding (8.26 years). However, there was no significant difference (p = 0.61) in the mean time from first publication to OREF grant when comparing NIH-funded Career Development Grant winners (12.0 years) and NIHfunded non-Career Development Grant winners (13.4 years). OREF awardees obtained NIH funding at a mean time of 6.3 years after their OREF award. There was no difference (p = 0.76) between the time from OREF award to NIH award for winners of Career Development Grants (6.4 years) and winners of nonCareer Development Grants (5.8 years).
Discussion
One of the stated goals of the OREF is to provide financial support to a broad variety of orthopaedic researchers to acquire preliminary data needed to apply for federal funding 1 . Between 1994 and 2014, the OREF awarded 121 faculty-level grants to fund 126 projects: 73 basic science projects, 45 clinical projects, and 8 epidemiological projects. In our analysis, 22% of OREF grant awardees successfully secured NIH funding, with a mean interval of 6.3 years between awards. Furthermore, 46% of Career Development Grant awardees later secured NIH funding. Given the limitation in the number of available NIH grants, our study sought to determine whether specific study types had a higher likelihood of acquiring NIH funding in the future. Interestingly, faculty with basic science projects that were funded by OREF were more than 4 times as likely to obtain NIH grants than faculty who had an OREF grant for a non-basic science project. Although the OREF may not prioritize basic science research, according to the data presented in this study, the NIH may have a preference for funding basic science research in the musculoskeletal area.
These outcomes are important given the current climate of restrictive funding within academic research, particularly concerning NIH grants 2, 4 . In 2014, the NIH received 52,073 grant applications and accepted 9,241 of them, resulting in a 17.7% success rate 3, 16 . The improved success rate of those orthopaedic faculty who have won OREF Career Development Grants, at a rate that is nearly triple the national average, points to the success of the OREF faculty grant programs in identifying promising scientists and supporting them as they establish their research careers.
Other studies within different specialties of medicine have also examined the relationship between NIH funding and their respective specialty-specific foundation funding. Eloy et al. looked at the relationship between full-time faculty members receiving a faculty grant from the American Academy of Otolaryngology-Head and Neck Surgery Foundation (AAO-HNSF) and showed that 39.6% of their investigators eventually later received NIH funding 17 . This is similar to the 22% of OREF Bar graph showing the relationship of NIH funding and the subspecialty of OREF grant awardees. The number of NIH-funded awardees is compared with the total number of OREF grant recipients from each subspecialty. 16, 2017 faculty-level grant awardees and 46% of Career Development Grant awardees who eventually acquired NIH funding and reinforces the fact that specialty-specific foundations are crucial in supporting the development of academic research in their respective fields of medicine.
The 5 OREF grants analyzed in this study vary with respect to the amount of funding awarded. The Career Development Grant is given to faculty members with promising research careers to promote a greater commitment to research. The monetary value of this award reflects this, as it amounts to as much as 4 times the value of the other individual grants ($134,000 to $225,000, compared with $50,000). In our analysis, Career Development Grant winners had a significantly higher h-index at the time that they received an OREF grant than non-Career Development Grant winners. It is important to recognize that a high h-index, as a positive predictor of future academic productivity, likely reflects a commitment to academic medicine and is thus self-selecting, particularly when it comes to seeking NIH grant funding. Thus, it is no surprise that even though non-Career Development Grants are awarded more often, winners of the Career Development Grant are nearly 4 times more likely to later receive NIH funding. The fact that OREF awards more of the smaller non-Career Development Grants than the larger Career Development Grants is a reflection of their stated mission to support a broad variety of clinically impactful orthopaedic research. Nonetheless, it appears that the Career Development Grant above all has been an effective funding source for faculty whom the OREF has identified as having promising research and is the OREF grant that is most likely to eventually lead to larger and more prestigious grant funding, such as NIH funding.
There were several limitations to this study. Our investigation only explored the relationship between OREF grants and NIH funding. This may have introduced some selection bias, as those with a commitment to basic science may have traditionally been more likely to submit applications for NIH grants. Although it is one of the largest sources for academic research support, NIH funding is not the only major grant funding resource. The U.S. Department of Defense (DoD), for example, funds a wide spectrum of medical research and provides millions of dollars of support toward orthopaedic research 18 . In addition, the Agency for Healthcare Research and Quality (AHRQ) and Patient-Centered Outcomes Research Institute (PCORI) are major funding institutions that do not have a basic science funding focus. However, the NIH is considered to be the gold standard for funding medical research, is the largest funder of orthopaedic research, and offers web-based transparency of awards through a searchable database 17, 19 . Therefore, although DoD funding and other federal sources were not considered, we believed that the clarity offered by a study investigating the conversion from an OREF grant to an NIH grant would nonetheless be of value. Future work could expand this project to assess other sources of subsequent funding. We also believe that understanding the relationship between OREF grant funding and NIH funding may provide valuable insight into academic success, and these findings may also be applied to other extramural sources of funding.
It is also important to acknowledge that the findings in this study are historical in nature. They imply correlation between funding types but do not demonstrate causality and thus are limited in their ability to inform future success or prognosticate the likelihood of success of research efforts. As the research landscape evolves and funding organizations become more receptive to patient-centered outcomes and other types of clinical research, funding patterns will likewise change. This relationship would be an important future direction of investigation.
In conclusion, the OREF grant awardee conversion rate of 22% and, particularly, the 46% rate for Career Development Grant winners demonstrate the importance of OREF grants as a source of initial funding for faculty researchers. Grants awarded by the OREF are not only important for supporting orthopaedic surgeons during the years that they are funded, but also achieve their purpose of identifying and supporting young researchers with the Career Development Grant, leading to an NIH funding rate that is nearly triple the 18% national average success rate for NIH funding applications. n Vishal Hegde, MD
